JPRN-UMIN000027674已完成1 期
A pharmacokinetic study of sodium phenylbutyrate in healthy adults for refractory pediatric cholestatic disease's therapy - A pharmacokinetic study of sodium phenylbutyrate in healthy adults
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Those who have hypersensitivity with phenylbutylate, its metabolites, drug additives and/or benzoate, etc. 2) Those who have experienced serious disease. 3) Those who have received medication in the previous two months. 4) Those who have received more than 200ml whole blood sampling in the previous 4 weeks, or blood component sampling in the previous 2 weeks. 5) Those who have received more than 400ml whole blood sampling in the previous 12 weeks. 6) Those who have been included in any phase 1 clinical trial for medicine containing new active ingredient in the previous 4 months. 7) Those who are less than 20 years old. 8) Drug addicts. 9) Alcoholics 10) Those who have been determined ineligible by principal investigator or sub-investigator.
研究者
相似试验
已完成
1 期
A pharmacokinetic study of sodium phenylbutyrate in urea cycle disorderurea cycle disorderJPRN-UMIN000025627Juntendo University5
已完成
1 期
A pharmacokinetic study of sodium phenylbutyrate in refractory pediatric cholestasis diseaseJPRN-UMIN000025037Juntendo University7
尚未招募
2 期
Investigating Sodium Butyrate as Treatment for Anorexia NervosaAnorexia NervosaACTRN12624000368538Monash University15
已完成
2 期
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle DisordersAmino Acid Metabolism, Inborn ErrorsNCT00004767National Center for Research Resources (NCRR)20
招募中
3 期
Effect of sodium butyrate in prevention and treatment of type 2 diabetesDiabetes mellitus Type 2.E10, E11,DiabetesIRCT20090609002017N33utrition Research Center, Tabriz University of Medical Science42